Next Generation Car T Cells for Lymphoma and Beyond

Hematological Oncology - United Kingdom
doi 10.1002/hon.2629
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Teaching an Old Dog New Tricks: Next-Generation CAR T Cells

British Journal of Cancer
Cancer ResearchOncology
2018English

CAR-T Cells Beyond CD19, UnCAR-Ted Territory

American Journal of Hematology
Hematology
2019English

CAR T Cells Beyond Cancer: Hope for Immunomodulatory Therapy of Infectious Diseases

Frontiers in Immunology
AllergyImmunology
2019English

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Cd30-Chimeric Antigen Receptor (Car) T Cells for Therapy of Hodgkin Lymphoma (Hl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Next-Generation Surveillance Strategies for Patients With Lymphoma

Future Oncology
MedicineCancer ResearchOncology
2015English

Anti-Car-Engineered T Cells for Epitope-Based Elimination of Autologous CAR T Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Chimeric Antigen Receptor T-Cells (Car-T) for Refractory and Relapsed Burkitt's Lymphoma: Early Response in Pediatric Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy